Loading market dashboard
Hikma Pharmaceuticals PLC
HIK.LHealthcareLSEGB
Loading analysis workspace
Estimates, scoring, valuation assumptions, and peer comparison in one research surface.
Hikma Pharmaceuticals PLC · Forecast overview
Bars show expected revenue while the line tracks expected EPS.
| Period | Revenue avg | Revenue range | EBITDA | EPS avg | Analysts |
|---|---|---|---|---|---|
| Dec 2030 | $4.18B | $4.13B - $4.25B | $1.05B | $3.559 | 7 |
| Dec 2029 | $4.01B | $3.96B - $4.07B | $1.01B | $2.84 | 7 |
| Dec 2028 | $3.81B | $3.76B - $3.87B | $960.03M | $2.633 | 8 |
| Dec 2027 | $3.64B | $3.58B - $3.72B | $916.74M | $2.443 | 9 |
| Dec 2026 | $3.47B | $3.44B - $3.51B | $875.73M | $2.219 | 9 |
| Dec 2025 | $3.32B | $3.30B - $3.34B | $837.39M | $2.238 | 9 |
| Dec 2024 | $3.09B | $3.06B - $3.10B | $778.56M | $2.191 | 8 |
| Dec 2023 | $3.82B | $3.77B - $3.88B | $962.71M | $1.635 | 7 |
| Dec 2022 | $2.53B | $2.44B - $2.63B | $681.52M | $1.791 | 4 |
| Dec 2021 | $2.51B | $2.48B - $2.52B | $643.83M | $1.919 | 5 |
| Dec 2020 | $2.32B | $2.30B - $2.34B | $601.15M | $1.686 | 5 |
| Dec 2019 | $2.11B | $2.09B - $2.12B | $373.07M | $1.396 | 4 |